Implementing personalized cancer genomics in clinical trials (Q38102920)

28 August 2017

Implementing personalized cancer genomics in clinical trials (English)

1 reference

28 August 2017

0 references

Richard Simon

1

1 reference

PubMed ID

23629504

28 August 2017

Sameek Roychowdhury

series ordinal

2

1 reference

28 August 2017

1 May 2013

1 reference

Nature Reviews Drug Discovery

28 August 2017

1 reference

28 August 2017

12

1 reference

28 August 2017

5

1 reference

28 August 2017

358-369

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd3979

28 August 2017

0 references

cites work

Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability

1 reference

A decade's perspective on DNA sequencing technology

21 January 2018

1 reference

International network of cancer genome projects

21 January 2018

1 reference

Big science: The cancer genome challenge

21 January 2018

1 reference

Profiling critical cancer gene mutations in clinical tumor samples

21 January 2018

1 reference

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

21 January 2018

1 reference

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing

21 January 2018

1 reference

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

21 January 2018

1 reference

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

21 January 2018

1 reference

Assuring the quality of next-generation sequencing in clinical laboratory practice

21 January 2018

1 reference

Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping

21 January 2018

1 reference

Advances in understanding cancer genomes through second-generation sequencing

21 January 2018

1 reference

SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data

21 January 2018

1 reference

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

21 January 2018

1 reference

Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV

21 January 2018

1 reference

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

21 January 2018

1 reference

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

21 January 2018

1 reference

Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data

21 January 2018

1 reference

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues

21 January 2018

1 reference

Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity

21 January 2018

1 reference

The ethical use of mandatory research biopsies

21 January 2018

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

Intratumor heterogeneity: evolution through space and time

21 January 2018

1 reference

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

21 January 2018

1 reference

Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents

21 January 2018

1 reference

Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations

21 January 2018

1 reference

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

21 January 2018

1 reference

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

21 January 2018

1 reference

The origin and evolution of mutations in acute myeloid leukemia

21 January 2018

1 reference

CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge

21 January 2018

1 reference

Personalized oncology through integrative high-throughput sequencing: a pilot study

21 January 2018

1 reference

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.

21 January 2018

1 reference

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.

21 January 2018

1 reference

RNA-Seq: a revolutionary tool for transcriptomics

21 January 2018

1 reference

BRAF inhibition in refractory hairy-cell leukemia.

21 January 2018

1 reference

Clinical trials for predictive medicine: new challenges and paradigms

21 January 2018

1 reference

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

21 January 2018

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

21 January 2018

1 reference

Role of randomized phase III trials in an era of effective targeted therapies

21 January 2018

1 reference

Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics

21 January 2018

1 reference

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

PTEN and the PI3-kinase pathway in cancer

21 January 2018

1 reference

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

21 January 2018

1 reference

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

21 January 2018

1 reference

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

21 January 2018

1 reference

Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer

21 January 2018

1 reference

Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.

21 January 2018

1 reference

Activating mutations of TOR (target of rapamycin).

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Human homolog of patched, a candidate gene for the basal cell nevus syndrome

21 January 2018

1 reference

Activating Smoothened mutations in sporadic basal-cell carcinoma

21 January 2018

1 reference

Targeting MET in cancer: rationale and progress

21 January 2018

1 reference

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

21 January 2018

1 reference

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

Shared and separate functions of polo-like kinases and aurora kinases in cancer

21 January 2018

1 reference

Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically

21 January 2018

1 reference

The role of FLT3 in haematopoietic malignancies

21 January 2018

1 reference

Targeting the MDM2-p53 interaction for cancer therapy

21 January 2018

1 reference

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

ROS1 rearrangements define a unique molecular class of lung cancers

21 January 2018

1 reference

High throughput interrogation of somatic mutations in high grade serous cancer of the ovary

21 January 2018

1 reference

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma

21 January 2018

1 reference

New dream team for melanoma therapy

21 January 2018

1 reference

"Stand up to cancer" focuses on accelerating promising research: campaign has raised approximately $180 million

31 March 2020

1 reference

Amplification of c-erbB-2 and aggressive human breast tumors?

31 March 2020

1 reference

Gastrointestinal stromal tumours: origin and molecular oncology.

31 March 2020

1 reference

The Catalogue of Somatic Mutations in Cancer (COSMIC)

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23629504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23629504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23629504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRD3979

1 reference

28 August 2017

1 reference

PubMed ID

23629504